elegant software that guides successful drug discovery
elegant software that guides successful drug discovery
innovative
drug discovery
technology
The Optibrium team works at the forefront of decision-analysis and predictive modelling research, developing innovative products that enhance the efficiency and productivity of drug discovery.
Software Solutions
Our Products
A complete package of fully integrated, elegant software for small molecule design, optimisation and data analysis. StarDrop helps you deliver optimally balanced, successful compounds, fast.
A proven artificial intelligence platform for active learning in drug discovery.
Harness your expert chemistry knowledge and the exploratory power of generative methods to identify optimal compounds faster. Inspyra continuously generates new compound ideas while learning from your interactions.
Enhance your expertise with artificial intelligence to make better decisions.
Keep up to date
News & Events
Optibrium appoints Steve Yemm as Chief Commercial Officer
Optibrium appoints Steve Yemm as Chief Commercial Officer New role will lead global commercial strategy and development as Optibrium continues to scale its drug discovery technologies and team. Latest in a series of senior hires as the Company continues its ... Read More
Optibrium appoints Ian Smith as Chief Technology Officer
Optibrium appoints Ian Smith as Chief Technology Officer New role will lead technology development as the Company continues to scale team and global business operations. The appointment of former Merck, Sharp and Dohme (MSD) Director of R&D Analytics ... Read More
Optibrium and Lhasa Limited advance predictive modelling for drug-metabolising enzymes
Optibrium and Lhasa Limited advance predictive modelling for drug-metabolising enzymes Optibrium and Lhasa Limited publish joint peer-reviewed research in the Journal of Medicinal Chemistry, expanding predictive modelling beyond human Cytochrome P450. Study ... Read More
Â
Our next webinar
Real world case studies: Predicting pharmacokinetics from limited ADME data with deep learning
9 February 2023 – 4:00pm (GMT)
Join The
Optibrium Community
Access a wealth of information on all of our products, learn more about our science and our wider community of collaborators.
Learn More
About Us
Founded in 2009, Optibrium continues to develop new products and research novel technologies to improve the efficiency and productivity of drug discovery. Optibrium works closely with its broad range of customers and collaborators that include leading global pharma, agrochemical and flavouring companies, biotechs and academic groups.
Got an Enquiry?
Get In Touch
To trial any of our products or to find out more about Optibrium, please complete the contact form and add details of your particular interest. Further information on our office locations and details can be found on our Contact page.